Zdrowie i gospodarka · 26/10/2005
FDA Releases Guidance for Industry on Modified-Release Potassium Chloride Dosage Forms
The FDA has made available a guidance document that provides recommendations for sponsors of abbreviated new drug applications (ANDAs) on designing bioequivalence studies for modified-release potassium chloride dosage forms, including tablets and capsules.
Source: Federal Register — Food and Drug AdministrationOpen original release →